HOW CAN WE PREVENT RECURRENT-DKA?
|
|
- Alisha Clarke
- 5 years ago
- Views:
Transcription
1 pinterest HOW CAN WE PREVENT RECURRENT-DKA? Birgit Rami-Merhar
2 DKA is not only a problem at the onset of T1D T1D-children at risk for recurrent DKA: 1-10%/patient/year (ISPAD 2014) mortality rate from DKA: % Cerebral edema accounts for 60 90% of all DKA deaths Complications: children without overt neurological symptoms during DKA treatment may have subtle evidence of brain injury, particularly memory deficits, after recovery from DKA Other complications (e.g. thrombosis, rhabdomyolysis, acute renal failure, )
3 Morbidity and Mortality of Diabetic Ketoacidosis With and Without Insulin Pump Care. Realsen, Chase et al. DIABETES TECHNOLOGY & THERAPEUTICS 2012 Review-Article 3 European population-based studies > T1D patients Onset death excluded DKA =most common cause of death in young T1D-patients DKA related death: 15-19% of all deaths Mortality due to DKA 3 times greater than for SH.
4 What has changed over the years?
5 Changes in Pediatric Diabetes Therapy over 20 yrs Bohn et al, DPV (Germany and Austria, n= 63,967 T1D <18yrs, Plos One 2016
6 Bohn et al, DPV (Germany and Austria, n= 63,967 T1D <18yrs, Plos One 2016
7 Improved Metabolic Control Rosenbauer et al, Diabetes Care 35:80 86, 2012
8 Who is at risk for recurrent DKA??
9 Hospital admission for DKA or SH in young patients with type 1 diabetes (GER/AUT). Karges et al., European Journal of Endocrinology (2015)
10 Maahs et al Diabetes Care 2015 Rates of Diabetic Ketoacidosis: International Comparison With 49,859 Pediatric Patients With Type 1 Diabetes From England, Wales, the U.S., Austria, and Germany Differences between the registries (HbA1c, pump-use and DKA-rate) Overall findings:
11 Girls Female Male Age (yrs) Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 167(4): Gerstl EM, et al. (2008)
12 Metabolic changes during puberty (adapted from Monatsschrift Kinderheilkunde 2015) insulinresistance insulindosage weight gain poor compliance omission of insulin eating disorder poor metabolic control DKA
13 Predictors of Acute Complications in Children With Type 1 Diabetes. Rewers et al (US) JAMA N=1243 <19 yrs T1D Denver, Colorado, Were followed up prospectively for from (5yrs) DKA: 8/100 Pat yrs
14 Psychiatric disorders in T1D youth Eating disorders depression anxiety Other psychiatric disorders (e.g.bipolar) Often underdiagnosed and undertreated
15 Identify those at risk for recurrent DKA (1-10%/patient/year), ISPAD guidelines 2014 Children who omit insulin Children with poor metabolic control or previous episodes of DKA Peripubertal and adolescent girls Gastroenteritis with persistent vomiting and inability to maintain hydration Children with psychiatric disorders, including those with eating disorders Children with difficult or unstable family circumstances (e.g. parental abuse) Children with limited access to medical services Insulin pump therapy still verifiable??
16 CSII and risk for DKA CSII may increase the risk for DKA (no long-acting insulin used) DKA-prevalence in CSII-Pat: 2,7-9/100 Pat-yrs Most frequent cause of DKA in CSII Omission of bolus (48,6%) Gastroenteritis (14,1%) Technical pump problems (12,7%) DKA-frequency not different between CSII and MDI DKA in young children with CSII: very rare Highest risk in adolescents (15-25 yrs) with CSII (T1DX) Fritsch M et al. Pediatric Diabetes 2011 Weissberg-Benchel J et al, Diabetes Care 2003 Hanas R et al Pediatric Diabetes 2009 Berghäuser MA et al. Pediatric Diabetes 2008 Philip M et al., Diabetes Care 2007 Karges et al., European Journal of Endocrinology 2015
17 Emergency plan for CSII and high BG If you are using Apidra/Humalog/Novo Rapid in your pump: Check blood-ketons if: BG is >250 mg/dl If you feel unwell/ vomiting/stomach ache Infection with fever
18 Any intervention programms evaluated? Diabet. Med. 32, (2015) Aim: to reduce hospital readmissions due to DKA, hyperglycemia or severe hypoglycemia N= 58 diabetes patients (50 T1D, mean age 35 yrs) readmitted consecutive patients 32/58 had a pre-existing mental health issue 14/58 had a complex social situation
19 Strategies implemented: Simmons et al., Diabet. Med. 32, (2015) Case manager gets in in contact with patient Establishes a relationship Home visit (60%) Patient education (94%) Mental health management Technology (34%,CSII, CGMS, BGM, Pens) Social intervention (32%) Support (78%) outside office hours (24/7-hotline, home visits) Clinical management (20%): sick days, co-morbidities
20 Monthly admission rates Simmons et al., Diabet. Med. 32, (2015)
21 Conclusion-recurrent DKA Recurrent DKA is an ongoing problem We need to identify the patients at risk Most frequent reason: omission of insulin Infection only is rarely the case CSII-therapy has no increased risk for DKA anymore Teach ketone measurement (preferably blood-ketones) 24h hotline Apps with sickday-management-advise could help
22 Conclusion-recurrent DKA Look for psychosocial reasons (e.g. eating disorder, depression, problems at home, insurance?) Engage a multidisciplinary team (including social workers and psychologists) Intensify diabetes education for those at risk and their caregivers (incl. school), have someone to observe insulin dosing Teach GP s and medical students to diagnose DKA Consider using CSII in recurrent DKA-patients It takes a lot of effort and support to reduce recurrent DKA
23 Still a lot to do.
24 Thank you for the attention!
Diabetes Management in Toddlers/Preschoolers (<6 yo)
Diabetes Management in Toddlers/Preschoolers (
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationLessons From The Type 1 Diabetes Exchange
Lessons From The Type 1 Diabetes Exchange Andrew Ahmann, MD Harold Schnitzer Diabetes Health Center at OHSU Presenter Disclosure Information In compliance with the accrediting board policies, the American
More information20 th. Diabetic ketoacidosis: update on management and prevention. Friday. October Innsbruck Hall ISPAD 2017
ISPAD 2017 October 18 th - 21 st Innsbruck - Austria A.Menarini Diagnostics Satellite Symposium Diabetic ketoacidosis: update on management and prevention 20 th Friday October 12.45-13.45 Innsbruck Hall
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationCLINICAL UTILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 1 DIABETES: A MACEDONIAN REPORT
University Department of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Sv. Kiril I Metodij University, Skopje, Macedonia Scientific Paper Received: February 19, 2007 Accepted: March
More informationDIAGNOSIS OF DIABETES NOW WHAT?
DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO
More informationABSTRACT BOOK All in all Diabetes management as a joint task
ABSTRACT BOOK All in all Diabetes management as a joint task ISPAD 2016 2017 Breakfast Symposium Valencia, Innsbruck, Spain Austria Thursday, October 27, 19, 2016 2017 Welcome to Innsbruck welcome to the
More informationType 1 Diabetes in Children and Adolescents
Type 1 Diabetes in Children and Adolescents Joseph Wolfsdorf Division of Endocrinology Boston Children s Hospital Harvard Medical School joseph.wolfsdorf@childrens.harvard.edu I have no relevant financial
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationDiabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System
Critical Care Guideline Two Bag System Inclusion Criteria (Definition of DKA): Blood glucose (BG) > 200 mg/dl Acidosis (bicarbonate < 15 or blood gas ph < 7.3) Associated glycosuria, ketonuria &/or ketonemia
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More informationEnsuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes
Ensuring Safe Physical Activity in Children and Adolescents With Type 1 Diabetes FACULTY ADVISOR Lori Laffel, MD, MPH Professor, Pediatrics Harvard Medical School Chief, Pediatric, Adolescent and Young
More informationApproach to the Young child & Parent with Child with DM Best Structure for Continued Care
Approach to the Young child & Parent with Child with DM Best Structure for Continued Care M.S. Limbe MD Paediatric Endcocrinologist Aga Khan University Hospital, Nairobi Approach to the Young Child & Parent
More informationFrom Childhood to Adulthood: Young Adult Transitions in Diabetes Care
From Childhood to Adulthood: Young Adult Transitions in Diabetes Care Lori Laffel, MD, MPH Chief, Pediatric, Adolescent and Young Adult Section Investigator, Genetics and Epidemiology Section Joslin Diabetes
More informationNHS GG&C Introduction of Freestyle Libre flash glucose monitoring system
NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid
More informationUpdate in the management of childhood-onset T1DM
KDA 2018 S2 Clinical diabetes & therapeutics 1 Update in the management of childhood-onset T1DM May 4, 2018 Jae Hyun Kim, MD Seoul National University Bundang Hospital Department of Pediatrics 본발표와관련된이해관계
More informationNew Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed
New Hires Program Canadian Diabetes Educator Certification Board Competencies Addressed Competency Pathophysiology 1.A Describes the pathophysiology and progression of all types of 1.B Distinguishes between
More informationCounting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice
Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric
More informationEuropean Perspective on Paediatric Diabetes Care
Keystone, Colorado, July 2013 Practical Ways to Achieve Targets in Diabetes Care European Perspective on Paediatric Diabetes Care Professor David Dunger Department of Paediatrics Practical Ways to Achieve
More informationClinical Guideline Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
ssociation of Children s Diabetes Clinical Guideline Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationEffectiveness Of A Diabetic Ketoacidosis Prevention Intervention In Children With Type 1 Diabetes
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Public Health Theses School of Public Health January 2015 Effectiveness Of A Diabetic Ketoacidosis Prevention Intervention
More informationFebruary 19, Dear Medical Director:
141 Northwest Point Blvd Elk Grove Village, IL 60007-1019 Phone: 847/434-4000 Fax: 847/434-8000 E-mail: kidsdocs@aap.org www.aap.org Executive Committee President Sandra G. Hassink, MD, FAAP President-Elect
More informationDiabetes Management: Current High Tech Innovations
Diabetes Management: Current High Tech Innovations How Far We ve Come in the Last 40 Years William V. Tamborlane, MD Department of Pediatrics Yale School of Medicine Disclosures I am a consultant for:
More informationEffectiveness of a Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1-1-2015 Effectiveness of a Diabetic Ketoacidosis Prevention Intervention
More informationGuideline on Sick day rules for children and young people with diabetes on insulin
Guideline on Sick day rules for children and young people with diabetes on insulin META DATA Title: Guidelines on Sick day rules for children and young people with Diabetes taking insulin Version: 1.0
More informationFamily Teamwork and Type 1 diabetes. Barbara J. Anderson, Ph.D. Professor of Pediatrics Baylor College of Medicine Houston, TX
Family Teamwork and Type 1 diabetes Barbara J. Anderson, Ph.D. Professor of Pediatrics Baylor College of Medicine Houston, TX Lessons from Research: What are the family factors that predict optimal adherence
More informationHypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??
Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier?? Moshe Phillip Institute of Endocrinology and Diabetes National Center of Childhood Diabetes Schneider
More informationEAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK. Optimising Glycaemic Control for Children and Young People with Diabetes
EAST OF ENGLAND CHILDREN AND YOUNG PEOPLE S DIABETES NETWORK Optimising Glycaemic Control for Children and Young People with Diabetes Local diabetes teams need to take on the responsibility of ensuring
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for
More informationPolicy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the
More informationMOVING ON... WITH DIABETES
MOVING ON... WITH DIABETES ADOLESCENT KNOWLEDGE & SKILLS CHECKLIST (AGE 17-18 YRS) DIABETES EDUCATOR/TEAM USER GUIDE PURPOSE Provides adolescent self-assessment of learning needs prior to transition. Provides
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationNutrition for Children with T1 Diabetes. Gail Spiegel, MS RD CDE Senior Instructor
Nutrition for Children with T1 Diabetes Gail Spiegel, MS RD CDE Senior Instructor 2018 ATDC Conference: Conflict of Interest I have no conflicts of Interest. I will not be speaking on off-label topics.
More informationClinical Value and Evidence of Continuous Glucose Monitoring
Clinical Value and Evidence of Continuous Glucose Monitoring 9402313-012 Objective To review the clinical value and the recent clinical evidence for Professional and Personal CGM Key Points CGM reveals
More informationDistinguishing T1D vs. T2D in Childhood: a case report for discussion
Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial
More informationState of California Health and Human Services Agency Department of Health Care Services
State of California Health and Human Services Agency Department of Health Care Services JENNIFER KENT Director EDMOND G. BROWN JR Governor DATE: N.L.: 03-0317 Index: Benefits TO: ALL COUNTY CALIFORNIA
More informationT1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center
T1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center T1D Exchange Mission and Goals Improve outcomes of people touched
More informationOVERVIEW OF PEDIATRIC DIABETES Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County
OVERVIEW OF PEDIATRIC DIABETES 2011 Alan B. Cortez, M.D. Pediatric Endocrinology Chief, Department of Pediatrics Kaiser-Permanente, Orange County Outline of Pediatric Diabetes Presentation Types of Pediatric
More informationAudit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)
Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
More informationTrust Guideline for the Management of: Insulin Pump Therapy in Children with Type 1 Diabetes
A clinical guideline recommended for use In: By: For: Key words: Written by: Supported by: Approved by: Jenny Lind Children s Department Jenny Lind Diabetes Team Children on CSII therapy CSII, Insulin
More informationThe Dangers of Diabulimia. What is Type 1 Diabetes?
3/15/17 The Dangers of Diabulimia What Every Person With Type 1 Needs to Know What is Type 1 Diabetes? An auto-immune disease in which the immune system attacks itself, destroying the insulin secreting
More informationPOSITION STATEMENT. May Early diagnosis of children with Type 1 diabetes. Key points
POSITION STATEMENT Title Date Early diagnosis of children with Type 1 diabetes May 2015 Key points Early diagnosis of Type 1 diabetes is essential to allow treatment to start as soon as possible. The classic
More informationMOVING ON... WITH DIABETES
MOVING ON... WITH DIABETES KNOWLEDGE & SKILLS SELF-ASSESSMENTS (AGES 13-16 YRS) DIABETES EDUCATOR/TEAM USER GUIDE PURPOSE Evaluates knowledge and skill level related to diabetes management. Directs further
More informationSARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE
SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: DKA / HHNS PATIENTS REQUIRING INTRAVENOUS INSULIN DRIPS -ADULTS Nursing DATE: REVIEWED: PAGES: 12/14 5/18 1 of 8 RESPONSIBILITY: *RN (Renal/Diabetes/Wound
More informationExercise Prescription in Type 1 Diabetes
Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,
More informationType I diabetes mellitus. Dr Laurence Lacroix
mellitus Dr Laurence Lacroix 26.03.2014 1 DEFINITION: Group of diseases characterized by a disorder of glucose homeostasis with high levels of blood glucose resulting from defects in : o insulin production
More informationGeorge Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital
George Ford MD MS Assistant Professor Pediatric Endocrinology ETSU and Niswonger Children s Hospital Disclosure Statement of Financial Interest I, George Ford MD MS, DO NOT have a financial interest/arrangement
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationTHE CURRENT APPROACH TO T1D IN CHILDREN
THE CURRENT APPROACH TO T1D IN CHILDREN Dina Panagiotopoulos, MD, FRCPC Associate Professor, Department of Pediatrics University of British Columbia Endocrinologist, BC Children s Hospital CFRI & CDA Clinician
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE TREATMENT OF HYPERGLYCEMIA - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity & Nutrition Strategic Clinical Network PARENT
More informationInsulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Outline of Material Introduction
More informationINSULIN THERAY دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد
INSULIN THERAY DIABETES1 IN TYPE دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد Goals of management Manage symptoms Prevent acute and late complications Improve quality of life Avoid
More informationType 1 Diabetes Update Robin Goland, MD
Naomi Berrie Diabetes Center Type 1 Diabetes Update 2008 Robin Goland, MD Type 1 diabetes is: A manageable condition A chronic condition Often challenging Entirely compatible with a happy and healthy childhood
More informationDIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address:
1 DIABETES Self Directed Test (12 Hours) Name: Ward/Practice Area: Mailing Address: 2 Learning Outcomes All nurses, regardless of practice setting, are required to work collaboratively with the person
More informationControl of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim
Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine Conflict of interest
More informationSick day management in children and adolescents with diabetes. Dr:P.Eshraghi Pediatric Endocrinologist Assistant professor of Mashhad Medical School
Sick day management in children and adolescents with diabetes Dr:P.Eshraghi Pediatric Endocrinologist Assistant professor of Mashhad Medical School الله الرحمن الرحيم بسم The effects of illness on diabetes
More informationChapter 11 summary definitief ineke brands.indd :57:59
chapter 11 Summary chapter 11 Both type 1 and type 2 diabetes mellitus are associated with altered brain function, a complication referred to as diabetic encephalopathy. Previous studies have shown that
More informationLOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA
LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA Anne Leake, PhD, APRN-Rx, BC-ADM ECHO Diabetes Learning Group 3/28/2018 Objectives 1. Identify common preventable causes of hypoglycemia
More informationDiabetes in obstetric patients
Diabetes in obstetric patients Swedish Society of Obstetric Anaesthesia & Intensive Care Anita Banerjee Obstetric Physician Diabetes & Endocrinology Consultant Outline Scope of the problem Diabetes and
More informationNew NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people
Article New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Helen Thornton This is the first of two articles on the 2015 NICE NG18 guideline,
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated
More informationQOF Indicator DM013:
QOF Indicator DM013: The percentage of patients with diabetes, on the register, who have a record of a dietary review by a suitably competent professional in the preceding 12 months Note: the bold signposts
More informationCDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017
CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017 DKA at organ level 3 Diabetic Ketoacidosis Characteristics Ketones positive Anion Gap > 12 (High) Blood Sugar > 14 (High) Bicarbonate
More informationI have no financial disclosures
Athina Sikavitsas DO Children's Emergency Services University of Michigan Discuss DKA Presentation Assessment Treatment I have no financial disclosures 1 6 Y/O male presents with vomiting and abdominal
More informationType 1 Diabetes: diagnosis and management. Stakeholder workshop
Type 1 Diabetes: diagnosis and management Stakeholder workshop 28 th May 2012 Royal College of Paediatrics & Child Health: 5-11 Theobalds Road, London WC1X 8SH Summary notes The stakeholder scoping workshop
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Continuous subcutaneous insulin infusion for the treatment of diabetes (review) Final scope Appraisal objective To review
More informationAn Evaluation of a Universal Funding Program for Pediatric Insulin Pumps in Ontario
An Evaluation of a Universal Funding Program for Pediatric Insulin Pumps in Ontario McMaster Endocrinology Rounds September 16, 2016 Rayzel Shulman MD, PhD, FRCPC German/Austrian Prospective Diabetes Follow-up
More informationI. Promoting Student Independence
The Nursing Support Services (NSS) Coordinator provides support according to the Provincial Standards: Supporting Students with Type 1 Diabetes in the School Setting. The NSS Coordinator delegates specific
More information11 year-old female with altered mental status in the setting of diabetic ketoacidosis
11 year-old female with altered mental status in the setting of diabetic ketoacidosis Katie O Sullivan, M.D. Fellow Adult/Pediatric Endocrinology University of Chicago Thursday, January 23 rd, 2014 Chief
More informationDiabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD
Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections Aaron Michels MD Outline SMBG & CGM by age group JDRF CGM Trial Sensor Augmented Insulin Pump Therapy for A1c Reduction
More informationGuideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation
CHILDREN S SERVICES Guideline for Children with Type 1 or Type 2 Diabetes on Insulin Requiring Surgery or Sedation Background Surgery places stress on the body and will alter glucose control and insulin
More informationHyperglycemia Procedure: Management and Treatment Adult Patients
Approved by: Chief Operating Officer; and Chief Medical Officer Hyperglycemia Procedure: Management and Treatment Corporate Policy & Procedures Manual Number: VII-B-465 Date Approved January 23, 2018 Date
More informationAdvances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?
Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier? Alan B Schorr DO FAAIM FACE www.sugardoc.com abs@sugardoc.com Disclosures
More informationDiabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical
Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical Practice Guideline Task Force Members Anne Peters, MD (Chair)
More informationWith Dr. Sarah Reid and Dr. Sarah Curtis
5. Headaches 6. Known diabetes 7. Specific high risk groups (ie. Teenagers, children on insulin pumps and those from lower socio-economic status). Episode 63 Pediatric Diabetic Ketoacidosis With Dr. Sarah
More informationInsulin pumps (CSII): Using Modern technology to communicate with families of children with type 1 diabetes
Insulin pumps (CSII): Using Modern technology to communicate with families of children with type 1 diabetes Grace Harris and Rita Sigley Paediatric Diabetes Nurse Specialists Starship children s Health
More informationGuidelines for the care of Children with Diabetes Mellitus undergoing Surgery
Guidelines for the care of Children with Diabetes Mellitus undergoing Surgery Background Surgery places physical and emotional stress on the body. This, alongside new surroundings, parental anxiety and
More informationMANAGEMENT OF TYPE 1 DIABETES MELLITUS
MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationThe Diabetes Team Auf der Bult
Treatment and Education of Children with Type 1 Diabetes and their Parents Sarah Bläsig Diabetes Educator Mail to: onset@hka.de The Diabetes Team Auf der Bult Outpatient Clinic and Ward since 1973 320
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationDiabetes Subcommittee of PTAC meeting held 3 March (minutes for web publishing)
Diabetes Subcommittee of PTAC meeting held 3 March 2011 (minutes for web publishing) Diabetes Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics
More informationNHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults
NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions
More informationDiabetic Ketoacidosis
Diabetic Ketoacidosis Definition: Diabetic Ketoacidosis is one of the most serious acute complications of diabetes. It s more common in young patients with type 1 diabetes mellitus. It s usually characterized
More informationPSYCHOSOCIAL EFFECTS OF MANAGING CGMS. Megan Purser, PhD
PSYCHOSOCIAL EFFECTS OF MANAGING CGMS Megan Purser, PhD DEPARTMENT OF PEDIATRICS OF PEDIATRICS Diabetes Management of the School-Aged Child Provided by Texas Children s Hospital Provider #18-267764-A February
More informationNational Paediatric Diabetes Audit
National Paediatric Diabetes Audit Parent and Carers Report 2015-16 Commissioned by the Healthcare Quality Improvement Partnership Managed by the Royal College of Paediatrics and Child Health National
More informationThis certificate-level program is non-sponsored.
Program Name: Diabetes Education : A Comprehensive Review Module 5 Intensive Insulin Therapy Planning Committee: Michael Boivin, B. Pharm. Johanne Fortier, BSc.Sc, BPh.LPh, CDE Carlene Oleksyn, B.S.P.
More informationSee accompanying articles, pp. 968, 979, 989, 997, 1008, 1016, 1030, and 1036.
Diabetes Care Volume 38, June 2015 971 CurrentStateofType1Diabetes Treatment in the U.S.: d Data From the T1D Exchange Clinic Registry Diabetes Care 2015;38:971 978 DOI: 10.2337/dc15-0078 Kellee M. Miller,
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationDiabetes in England NHS Medical Directorate. Dr Rowan Hillson MBE National Clinical Director for Diabetes
Diabetes in England 2010 Dr Rowan Hillson MBE National Clinical Director for Diabetes I strongly believe that Everyone with diabetes deserves the highest standards of personalised diabetes care, no matter
More informationPolicy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus
Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Version No. Changes Made Version of 05.10.2018 V1 Policy ratified by Healthier
More informationDIABETES IN ADOLESCENTS AND YOUNG ADULTS. Rasa VERKAUSKIENĖ LITHUANIAN UNIVERSITY OF HEALTH SCIENCES
DIABETES IN ADOLESCENTS AND YOUNG ADULTS Rasa VERKAUSKIENĖ LITHUANIAN UNIVERSITY OF HEALTH SCIENCES EASD Postgraduate Course 2017 TYPE 1 in ADOLESCENCE and YOUNG ADULTS Major advances past 30 yrs No reduction
More informationType 1 Diabetes and Eating Disorders
2/11/217 Type 1 Diabetes and Eating Disorders Marietta Stadler In type 1 diabetes (T1DM) eating disorders (ED) are a common complex problem 4, adults in the UK with T1DM 3% of women 1,2 and 7% of men 3
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in
More informationExercise in the recreational and competitive athlete with type 1 diabetes- the benefits, the risks and management strategies
Exercise in the recreational and competitive athlete with type 1 diabetes- the benefits, the risks and management strategies Craig E. Taplin, MD Division of Endocrinology and Diabetes Seattle Children
More information